<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE ArticleSet PUBLIC "-//NLM//DTD PubMed 2.7//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/in/PubMed.dtd">
<ArticleSet>
<Article>
<Journal>
				<PublisherName>Mazandaran Association of Emergency Medicine</PublisherName>
				<JournalTitle>Translational Health Reports</JournalTitle>
				<Issn>3092-6750</Issn>
				<Volume>1</Volume>
				<Issue>1</Issue>
				<PubDate PubStatus="epublish">
					<Year>2025</Year>
					<Month>09</Month>
					<Day>13</Day>
				</PubDate>
			</Journal>
<ArticleTitle>Post-Stroke Dysphagia: Clinical Screening with GUSS and Its Role in , Tailored Nutritional Therapy</ArticleTitle>
<VernacularTitle></VernacularTitle>
			<FirstPage>1</FirstPage>
			<LastPage>10</LastPage>
			<ELocationID EIdType="pii">229210</ELocationID>
			
<ELocationID EIdType="doi">10.22034/thr.2025.229210</ELocationID>
			
			<Language>EN</Language>
<AuthorList>
<Author>
					<FirstName>Saaedeh</FirstName>
					<LastName>Chalaki</LastName>
<Affiliation>Department of Emergency Medicine, Mazandaran University of Medical Sciences, Sari, Iran</Affiliation>

</Author>
<Author>
					<FirstName>Hossein</FirstName>
					<LastName>Montazer</LastName>
<Affiliation>Department of Emergency Medicine, Mazandaran University of Medical Sciences, Sari, Iran</Affiliation>

</Author>
<Author>
					<FirstName>Mirsaeed</FirstName>
					<LastName>Ramazani</LastName>
<Affiliation>Department of Emergency Medicine, Mazandaran University of Medical Sciences, Sari, Iran</Affiliation>

</Author>
</AuthorList>
				<PublicationType>Journal Article</PublicationType>
			<History>
				<PubDate PubStatus="received">
					<Year>2025</Year>
					<Month>09</Month>
					<Day>13</Day>
				</PubDate>
			</History>
		<Abstract> Background: This investigation explored the clinical utility of the Gugging Swallowing &lt;br /&gt;Screen (GUSS) in identifying swallowing dysfunction following stroke and examined its &lt;br /&gt;application in designing individualized nutritional interventions. The study also assessed a &lt;br /&gt;set of physiological markers—brain-derived neurotrophic factor (BDNF), salivary cortisol, &lt;br /&gt;leptin, and growth differentiation factor-15 (GDF-15)—to determine their relationship with &lt;br /&gt;dysphagia severity, neural recovery, and clinical prognosis. &lt;br /&gt;Methods: A cohort of 174 individuals recovering from stroke underwent swallowing &lt;br /&gt;assessments using both the GUSS protocol and the traditional water swallow test (WST). &lt;br /&gt;Participants diagnosed with swallowing impairments were randomized into a control group &lt;br /&gt;(CG), which received standard medical care, and an observation group (OG), which received &lt;br /&gt;additional GUSS-guided stratified feeding regimens. Comparative analyses focused on &lt;br /&gt;changes in swallowing ability, emotional well-being, serum and salivary biomarker profiles, &lt;br /&gt;and occurrence of medical complications. &lt;br /&gt;Findings: GUSS outperformed WST in sensitivity and responsiveness (P &lt; 0.05), as shown &lt;br /&gt;by significantly higher effect size (ES) and standardized response mean (SRM). Patients in &lt;br /&gt;the OG exhibited notably greater improvement in deglutition function and fewer adverse &lt;br /&gt;outcomes than those in the CG (P &lt; 0.05). Post-treatment nutritional markers—albumin &lt;br /&gt;(Alb), prealbumin (PA), and transferrin (TNF)—were also more favorable in the OG. BDNF &lt;br /&gt;and leptin levels showed strong alignment with dysphagia grading, while elevated salivary &lt;br /&gt;cortisol was associated with stress-related swallowing issues. GDF-15 levels correlated &lt;br /&gt;significantly with dysphagia-related complications. Moreover, quality of life indicators—&lt;br /&gt; including mental, physical, and social dimensions—were significantly enhanced in the OG (P &lt;br /&gt;&lt; 0.05). &lt;br /&gt;Conclusion: GUSS proves to be a robust tool for early detection of post-stroke swallowing &lt;br /&gt;disorders and offers added clinical value when used to guide dietary intervention. The &lt;br /&gt;inclusion of stress, neuroplasticity, and inflammatory biomarkers—particularly salivary &lt;br /&gt;cortisol and GDF-15—adds depth to severity assessment and supports the development of &lt;br /&gt;personalized rehabilitation pathways.</Abstract>
		<ObjectList>
			<Object Type="keyword">
			<Param Name="value">Post</Param>
			</Object>
			<Object Type="keyword">
			<Param Name="value">stroke dysphagia GUSS Individualized nutrition Biomarker profiling Neurorehabilitation</Param>
			</Object>
		</ObjectList>
<ArchiveCopySource DocType="pdf">https://www.threports.com/article_229210_2912e8ed2610efd39744cf62fce80a9b.pdf</ArchiveCopySource>
</Article>
</ArticleSet>
